Evripidis Gavathiotis
Keine laufenden Positionen mehr
Karriereverlauf von Evripidis Gavathiotis
Ehemalige bekannte Positionen von Evripidis Gavathiotis
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Bakx Therapeutics, Inc.
 Bakx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bakx Therapeutics, Inc. develops novel cancer therapeutics. The company is based in DE. The American company was founded by Evripidis Gavathiotis, Loren David Walensky, Sree Kant. Sree Kant has been the CEO of the company since 2020. | Gründer | 01.05.2020 | - |
Stelexis Therapeutics LLC
 Stelexis Therapeutics LLC Pharmaceuticals: MajorHealth Technology Stelexis Therapeutics LLC focuses on identifying and isolating the earliest definable stem and progenitor cells, which harbor clonal properties and pre-cancerous alterations. The company was founded by Ulrich Steidl, Derrick Rossi, Amit Verma, Evripidis Gavathiotis, and Roman Perez-Soler in 2017 and is headquartered in New York ,NY. | Gründer | 01.01.2017 | - |
Statistik
International
| Vereinigte Staaten | 3 |
Operativ
| Founder | 2 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Stelexis Therapeutics LLC
Stelexis Therapeutics LLC Pharmaceuticals: MajorHealth Technology Stelexis Therapeutics LLC focuses on identifying and isolating the earliest definable stem and progenitor cells, which harbor clonal properties and pre-cancerous alterations. The company was founded by Ulrich Steidl, Derrick Rossi, Amit Verma, Evripidis Gavathiotis, and Roman Perez-Soler in 2017 and is headquartered in New York ,NY. | Health Technology |
Bakx Therapeutics, Inc.
Bakx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bakx Therapeutics, Inc. develops novel cancer therapeutics. The company is based in DE. The American company was founded by Evripidis Gavathiotis, Loren David Walensky, Sree Kant. Sree Kant has been the CEO of the company since 2020. | Health Technology |
- Börse
- Insiders
- Evripidis Gavathiotis
- Erfahrung
